Hookipa Pharma Inc Stock Ownership - Who owns Hookipa Pharma?

Insider buying vs selling

Have Hookipa Pharma Inc insiders been buying or selling?
Reinhard KanderaChief Financial Officer2023-08-217,000$0.73
Reinhard KanderaChief Financial Officer2023-08-168,000$0.71
Jorn AldagChief Executive Officer2023-07-115,000$0.83
Jorn AldagChief Executive Officer2023-07-075,000$0.81
Jorn AldagChief Executive Officer2023-07-055,000$0.89
Jorn AldagChief Executive Officer2023-07-035,000$0.89
Reinhard KanderaChief Financial Officer2023-06-3012,000$0.88

1 of 1

HOOK insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when HOOK insiders and whales buy or sell their stock.

HOOK Shareholders

What type of owners hold Hookipa Pharma Inc stock?
Artal Group Sa6.75%5,666,410$3.49MInstitution
Knoll Capital Management LLC6.57%5,517,385$3.40MInstitution
Fmr LLC5.75%4,827,444$2.97MInstitution
Ecor1 Capital LLC5.47%4,595,024$2.83MInstitution
Baker Bros Advisors LP5.27%4,425,535$2.73MInstitution
Armistice Capital LLC4.59%3,856,000$2.38MInstitution
Gilead Sciences Inc4.48%3,759,465$2.32MInsider
Redmile Group LLC3.92%3,288,469$2.03MInstitution
Sofinnova Capital Vi Fcpr3.79%3,177,574$1.96MInsider
Alyeska Investment Group LP3.70%3,109,436$1.92MInstitution

1 of 3

HOOK vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
HOOK54.12%13.75%Net BuyingNet Buying
DNTH52.83%47.17%Net SellingNet Buying
SLDB22.16%77.84%Net Buying

Hookipa Pharma Stock Ownership FAQ

Who owns Hookipa Pharma?

Hookipa Pharma (NASDAQ: HOOK) is owned by 54.12% institutional shareholders, 13.75% Hookipa Pharma insiders, and 32.13% retail investors. Gilead Sciences Inc is the largest individual Hookipa Pharma shareholder, owning 3.76M shares representing 4.48% of the company. Gilead Sciences Inc's Hookipa Pharma shares are currently valued at $2.25M.

If you're new to stock investing, here's how to buy Hookipa Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.